Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CareDx, Inc. - Common Stock (NQ:CDNA)

39.73 -0.61 (-1.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CareDx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
What's going on in today's session ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination
From CareDx, Inc.
Via Business Wire
CareDx (NASDAQ:CDNA) Passes Both the Minervini Trend Template and High Growth Momentum Tests ↗
Via Chartmill
CAREDX INC (NASDAQ:CDNA) Shows Perfect Minervini Trend Template and High Growth Momentum Setup ↗
Via Chartmill
CareDx (NASDAQ:CDNA) Beats Q1 Estimates and Raises Full-Year Guidance, But Stock Slips ↗
Via Chartmill
News headline image
CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific
From CareDx, Inc.
Via Business Wire
News headline image
CareDx's CEO Sells 17K Shares ↗
CareDx, a leader in transplant diagnostics, saw a key insider reduce his direct holdings amid a series of scheduled transactions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans ↗
CareDx (NASDAQ:CDNA) executives outlined the company’s strategy to focus on precision diagnostics, expand into minimal residual disease testing and improve profitability during a Goldman Sachs-hosted... 
Via MarketBeat
Topics Intellectual Property
News headline image
CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies ↗
CareDx (NASDAQ:CDNA) executives outlined the company’s growth strategy, first-quarter performance and pipeline priorities during a presentation at the Jefferies Healthcare Conference, emphasizing... 
Via MarketBeat
News headline image
CareDx to Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Dismissal of 2021 Qui Tam Suit
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
News headline image
CareDx (CDNA) Q1 2026 Earnings Call Transcript ↗
CareDx (CDNA) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
Via Chartmill
News headline image
CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces First Quarter 2026 Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx (CDNA) Q2 2025 Earnings Transcript ↗
CareDx (CDNA) Q2 2025 Earnings Transcript 
Via The Motley Fool
News headline image
CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th Annual Meeting
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing
From CareDx, Inc.
Via Business Wire
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
News headline image
CareDx (CDNA) Q4 2025 Earnings Call Transcript ↗
CareDx (CDNA) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.